Abiomed, Inc.
ABMD · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $136,505 | $225,525 | $203,009 | $259,016 |
| Dep. & Amort. | $28,089 | $24,097 | $20,430 | $14,121 |
| Deferred Tax | $2,413 | $29,380 | $32,953 | -$7,745 |
| Stock-Based Comp. | $52,729 | $47,006 | $39,781 | $0 |
| Change in WC | -$30,196 | -$17,386 | $8,025 | -$38,841 |
| Other Non-Cash | $95,850 | -$34,044 | $10,722 | -$28,848 |
| Operating Cash Flow | $285,390 | $274,578 | $314,920 | $252,197 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$35,763 | -$53,383 | -$44,006 | -$44,004 |
| Net Acquisitions | -$82,821 | -$52,183 | $0 | $0 |
| Inv. Purchases | -$805,919 | -$582,303 | -$632,237 | -$404,337 |
| Inv. Sales/Matur. | $543,513 | $464,525 | $550,788 | $331,886 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$380,990 | -$223,344 | -$125,455 | -$116,455 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7,234 | $5,479 | $5,103 | $3,052 |
| Stock Repurch. | $0 | -$11,310 | -$84,879 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,202 | -$8,067 | -$117,715 | -$55,775 |
| Financing Cash Flow | -$2,202 | -$8,067 | -$117,715 | -$55,775 |
| Forex Effect | -$2,090 | -$2,798 | -$430 | -$1,921 |
| Net Chg. in Cash | -$99,892 | $40,369 | $71,320 | $78,046 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $232,710 | $192,341 | $121,021 | $42,975 |
| End Cash | $132,818 | $232,710 | $192,341 | $121,021 |
| Free Cash Flow | $249,627 | $221,195 | $270,914 | $208,193 |